Clinical Trial Update: Coronary Hybrid Revascularisation Study [NA]

View source ↗

Summary

Clinical trial update for the Coronary Hybrid Revascularisation Study (NCT01496664) indicates the trial has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Aarhus University Hospital Skejby | Conditions: Significant Coronary Artery Disease | NA | Status: COMPLETED